See also this year's filing and all EDGAR filings for this company.
PDF Report 0001708331_2023_Virpax_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001708331, Virpax Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 19,673,649 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 3,094,590 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,082,463 |
| 9 | ResearchAndDevelopmentExpense | 10,762,670 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 194,413 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 19,673,649 |
| 1 | Liabilities | 3,094,590 |
| 2 | Expenses | 21,845,133 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 16,579,059 |
| 5 | NetIncome | -21,650,720 |
| 6 | ComprehensiveNetIncome | -21,650,720 |
| 7 | BaseVar | 22,403,892 |
| 8 | EconomicCapitalRatio | 0.603 |
Edgar->Model Mapping
Feature Distribution
Change over Time
